Global advances in prostate cancer diagnosis and therapy
基本信息来源于合作网站,原文需代理用户跳转至来源网站获取
摘要:
There is a lot to learn from transnational research collaboration,and the Prostate Cancer Foundation (PCF) is dedicated to building bridges around the world to address complex scientific and clinical issues related to the development of improved diagnostics and therapeutics for metastatic prostate cancer.With the goal of improving patient care for men with prostate cancer globally,the multidisciplinary Sixth Annual Forum of Prostate Disease (6th FPD) was convened during 8-9 June 2012 in Shanghai,China.This conference provided an opportunity for scientists and clinicians from major medical centers in the United States and China to share data and forge new professional relationships.This special issue of the Asian Journal ofAndrology (AJA)provides an overview of the major presentations at the 6th FPD,which highlighted prostate cancer biology,genetics,new clinical therapies,imaging technologies and the biotechnology of new diagnostic tests capable of identifying patients destined for unfavorable outcomes.